Patents by Inventor Sarah A. Molokhia

Sarah A. Molokhia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF MYOPIA
    Publication number: 20240122974
    Abstract: The present invention provides methods of treating myopia comprising administering composition comprising a cop-per-containing agent to an eye of a subject in need thereof.
    Type: Application
    Filed: February 11, 2022
    Publication date: April 18, 2024
    Applicant: University of Utah Research Foundation
    Inventors: Balamurali Ambati, Sarah A. Molokhia
  • TREATMENT OF ASTIGMATISM
    Publication number: 20240091255
    Abstract: The present invention provides methods of treating corneal astigmatism comprising administering composition comprising a copper-containing agent to an eye of a subject in need thereof.
    Type: Application
    Filed: January 28, 2022
    Publication date: March 21, 2024
    Inventors: Balamurali Ambati, Sarah A. Molokhia
  • TREATMENT OF MYOPIC PROGRESSION
    Publication number: 20230256012
    Abstract: An ophthalmic composition or dosage form can include a therapeutically effective amount of a copper-containing agent that is sufficient to increase corneal lysyl oxidase activity in an eye of a subject in an amount sufficient to treat myopic progression and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat or prevent progression of myopia by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.
    Type: Application
    Filed: December 13, 2022
    Publication date: August 17, 2023
    Applicant: University of Utah Research Foundation
    Inventors: Randon Michael Burr, Balamurali K. Ambati, Sarah A. Molokhia
  • Treatment of myopic progression
    Patent number: 11524032
    Abstract: An ophthalmic composition or dosage form can include a therapeutically effective amount of a copper-containing agent that is sufficient to increase corneal lysyl oxidase activity in an eye of a subject in an amount sufficient to treat myopic progression and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat or prevent progression of myopia by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: December 13, 2022
    Assignee: University of Utah Research Foundation
    Inventors: Randon Michael Burr, Balamurali K. Ambati, Sarah A. Molokhia
  • MULTI-AGENT OCULAR FORMULATIONS AND TREATMENT METHODS
    Publication number: 20220288114
    Abstract: Opthalmic compositions are disclosed and described herein. In some embodiments, an ophthalmic composition can include as active agents a copper-containing agent and a secondary therapeutic agent in combination with a pharmaceutically acceptable carrier. The active agents can be present in amounts sufficient to treat myopic progression during a treatment period.
    Type: Application
    Filed: July 13, 2020
    Publication date: September 15, 2022
    Applicant: University of Utah Research Foundation
    Inventors: Randon Michael Burr, Balamurali K. Ambati, Sarah A. Molokhia
  • TREATMENT OF MYOPIC PROGRESSION
    Publication number: 20210060059
    Abstract: An ophthalmic composition or dosage form can include a therapeutically effective amount of a copper-containing agent that is sufficient to increase corneal lysyl oxidase activity in an eye of a subject in an amount sufficient to treat myopic progression and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat or prevent progression of myopia by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.
    Type: Application
    Filed: January 7, 2019
    Publication date: March 4, 2021
    Applicant: University of Utah Research Foundation
    Inventors: Randon Michael Burr, Balamurali K. Ambati, Sarah A. Molokhia